What is breast implant illness, and should it prompt removal?
Systemic symptoms some patients attribute to implants have no confirmed diagnostic test, and the explant decision weighs symptom burden against surgical realities.
Breast implant illness, or BII, is the patient-coined term for systemic symptoms — fatigue, joint pain, brain fog, and others — attributed to implants. It has no confirmed diagnostic test, which makes the explant decision a judgment call rather than a protocol.
What is known, and how to approach the decision
Research has not established a causal mechanism or diagnostic criteria for BII, but regulators take the reports seriously: the FDA now requires implant labeling to mention systemic symptoms some patients report, and studies continue. Because the symptom list overlaps with thyroid disease, autoimmune conditions, anemia, and menopause, a sensible first step is a medical workup that looks for treatable causes before attributing everything to the device.
Some patients report feeling better after explant and some do not; the response cannot be predicted for an individual in advance. An unhurried decision made in consultation with both a primary physician and a plastic surgeon — after other causes are checked, with realistic expectations about what surgery can and cannot resolve — serves patients better than urgency in either direction.
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.